GENEVA, Nov. 6 -- PRISETREE INTELLIGENT DRUGS, INC. filed a patent application (CN2026/093267) for “INHALABLE NINTEDANIB-CONTAINING PHARMACEUTICAL COMPOSITION AND USE THEREOF”. With publication no. WO/2026/228582, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: A61K 9/72

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....